Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Naltrexone in Pathological Gambling Disorder
NCT00053677Phase 3Completed
- Sponsor
- University of Chicago
- Start
- Dec 2002
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of naltrexone in gambling disorder (GD), sponsored by University of Chicago. Started Dec 2002; status: completed.
02
Drugs
naltrexone
03
Conditions
gambling disorder (GD)
Beyond the preview
Go deeper on NCT00053677.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00053677.